Acute Lung Injury Induced by Hyperbaric Oxygen or Other External Factors, with a Focus on Exosomes
Open Access
- 14 January 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (2) , 836
Abstract
Acute lung injury (ALI) is in part precipitated by hyperbaric oxygen or other mechanical insults. It constitutes the fundamental pathological process underlying acute respiratory distress syndrome (ARDS). The manifestation of the condition is characterized by an uncontrolled inflammatory response and alveolar edema, consequent to the disruption of the alveolar–capillary barrier. This phenomenon is associated with elevated morbidity and mortality rates. The current therapeutic interventions for ALI are not well researched or articulated. However, recent studies have indicated that stem cells may possess therapeutic potential in the context of ALI. The present study demonstrates that these exosome preparations have the capacity to significantly ameliorate radiographic findings, histological parameters, and vascular permeability in murine models of ALI. Concurrently, they attenuate the inflammatory response to a certain extent. The present review commences with an examination of the pathogenic mechanisms and manifestations of pulmonary injury induced by hyperbaric oxygen or other external factors. The subsequent sections of the text provide detailed accounts of the latest advances in exosome-based therapies for mitigating such injury, including their mechanisms of action and future translational prospects. While exosome-based treatments have demonstrated considerable advancement in preclinical research, numerous challenges must be surmounted before their widespread implementation in clinical settings can be realized, underscoring the necessity for sustained research in this domain.Keywords
This publication has 161 references indexed in Scilit:
- MitoEVs: A new player in multiple disease pathology and treatmentJournal of Extracellular Vesicles, 2023
- Single‐cell transcriptome atlas of human mesenchymal stem cells exploring cellular heterogeneityClinical and Translational Medicine, 2021
- PI3K signalling in chronic obstructive pulmonary disease and opportunities for therapyThe Journal of Pathology, 2021
- Extracellular vesicles from monocyte/platelet aggregates modulate human atherosclerotic plaque reactivityJournal of Extracellular Vesicles, 2021
- Stem cell therapy for COVID‐19: Possibilities and challengesCell Biology International, 2020
- Human umbilical cord mesenchymal stem cell‐derived extracellular vesicles: A novel therapeutic paradigmJournal of Cellular Physiology, 2019
- Mesenchymal stem cells: Cell therapy and regeneration potentialJournal of Tissue Engineering and Regenerative Medicine, 2019
- Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung RepairStem Cells Translational Medicine, 2018
- Human Pluripotent Stem Cell‐Derived Mesenchymal Stem Cells Prevent Allergic Airway Inflammation in MiceStem Cells, 2012
- Analysis of Tissues Following Mesenchymal Stromal Cell Therapy in Humans Indicates Limited Long-Term Engraftment and No Ectopic Tissue FormationStem Cells, 2012